Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Linnebank

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Neurology|February 3, 2017
Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosisLinard Filli, Björn Zörner, Sandra Kapitza, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 31, 2012
Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: results from the German Investigation on Neurobiology in Alcoholism (GINA)Peter Heese, Michael Linnebank, Alexander Semmler, et al.
Human Mutation|September 15, 2004
The cystathionine beta-synthase (CBS) mutation c.1224-2A>C in Central Europe: Vitamin B6 nonresponsiveness and a common ancestral haplotypeMichael Linnebank, Miroslav Janosik, Viktor Kozich, et al.
Alcohol (Fayetteville, N.Y.)|February 23, 2015
Alcohol abuse and cigarette smoking are associated with global DNA hypermethylation: results from the German Investigation on Neurobiology in Alcoholism (GINA)Alexander Semmler, Peter Heese, Birgit Stoffel-Wagner, et al.
Neuro-Degenerative Diseases|June 5, 2010
S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's diseaseMichael Linnebank, Julius Popp, Yvo Smulders, et al.
Scientific Reports|March 23, 2018
Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over timeLinard Filli, Tabea Sutter, Christopher S Easthope, et al.
CNS Drugs|December 12, 2018
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release FampridineJeremy Hobart, Tjalf Ziemssen, Peter Feys, et al.
Acta Neuropathologica|June 25, 2017
Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathologyBenjamin V Ineichen, Sandra Kapitza, Christiane Bleul, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Neurology|February 3, 2017
Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosisLinard Filli, Björn Zörner, Sandra Kapitza, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 31, 2012
Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: results from the German Investigation on Neurobiology in Alcoholism (GINA)Peter Heese, Michael Linnebank, Alexander Semmler, et al.
Human Mutation|September 15, 2004
The cystathionine beta-synthase (CBS) mutation c.1224-2A>C in Central Europe: Vitamin B6 nonresponsiveness and a common ancestral haplotypeMichael Linnebank, Miroslav Janosik, Viktor Kozich, et al.
Alcohol (Fayetteville, N.Y.)|February 23, 2015
Alcohol abuse and cigarette smoking are associated with global DNA hypermethylation: results from the German Investigation on Neurobiology in Alcoholism (GINA)Alexander Semmler, Peter Heese, Birgit Stoffel-Wagner, et al.
Neuro-Degenerative Diseases|June 5, 2010
S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's diseaseMichael Linnebank, Julius Popp, Yvo Smulders, et al.
Scientific Reports|March 23, 2018
Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over timeLinard Filli, Tabea Sutter, Christopher S Easthope, et al.
CNS Drugs|December 12, 2018
Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release FampridineJeremy Hobart, Tjalf Ziemssen, Peter Feys, et al.
Acta Neuropathologica|June 25, 2017
Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathologyBenjamin V Ineichen, Sandra Kapitza, Christiane Bleul, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meetingPhilipp Albrecht, Ingrid Kristine Bjørnå, David Brassat, et al.
Neuro-Oncology|September 23, 2008
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphomaMichael Linnebank, Susanna Moskau, Annika Jürgens, et al.
Pageof 11